Show simple item record

Depositordc.contributorValdés Hernández, Maria
Funderdc.contributor.otherRow Fogo Charitable Trusten_UK
Time Perioddc.coverage.temporalstart=1988-06; end=2014-10; scheme=W3C-DTFen
Data Creatordc.creatorValdés Hernández, Maria del C
Data Creatordc.creatorWardlaw, Joanna
Data Creatordc.creatorMuñoz Maniega, Susana
Date Accessioneddc.date.accessioned2017-04-27T11:04:08Z
Date Availabledc.date.available2017-05-03T04:15:41Z
Citationdc.identifier.citationValdés Hernández, Maria del C; Wardlaw, Joanna; Muñoz Maniega, Susana. (2017). Summary of the computational white matter hyperintensities assessment methods applied to clinical research up to October 2014, 1988-2014 [text]. University of Edinburgh. Centre for Clinical Brain Sciences. https://doi.org/10.7488/ds/2003.en
Persistent Identifierdc.identifier.urihttps://hdl.handle.net/10283/2665
Persistent Identifierdc.identifier.urihttps://doi.org/10.7488/ds/2003
Dataset Description (abstract)dc.description.abstractThis table summarises all the white matter hyperintensities (WMH) volume measurement methods used in different studies up to October 2014, and is referred to in the paper entitled "What are white matter hyperintensities made of? Relevance to vascular cognitive impairment" published by the Journal of the American Heart Association in June 2015, (number 6 of the volume 4), doi: 10.1161/JAHA.114.001140, PMC4599520. The publication is a commissioned Review on the nature of WMH, and the advances in brain magnetic resonance imaging (MRI) that show WMH at earlier stages and changes in normal-appearing white matter that indicate tissue pathology, less marked than those found in WMH. The abstract of the publication reads: White matter hyperintensities (WMH) of presumed vascular origin, also referred to as leukoaraiosis, are a very common finding on brain magnetic resonance imaging (MRI) or computed tomography (CT) in older subjects and in patients with stroke and dementia. They are associated with cognitive impairment, triple the risk of stroke and double the risk of dementia. Knowledge of their pathology derives mostly from post mortem studies, many from some years ago. These, by their nature, were generally small, sampled from selected brain regions and probably reflect late-stage disease. They focus on features of demyelination and axonal degeneration, which may be easier to detect histopathologically than changes in extracellular fluid. Here we review advances in brain magnetic resonance imaging (MRI) that are revealing white matter hyperintensities at earlier stages, and changes in normal-appearing white matter that indicate tissue pathology, less marked than those found in WMH. These “pre-visible” changes show that altered interstitial fluid mobility and water content, which may be reversible, probably predate demyelination and axonal damage, which are less likely to be reversible and are probably a late-stage phenomenon. Neuroimaging is also revealing the dynamic nature of WMH, their interactions with other pathological features such as secondary cortical and long tract damage, and contribution to accumulating brain damage. These insights provide opportunities to improve understanding the etiology and pathogenesis of small vessel disease, and represents an enormous unfinished agenda for preventing accumulation of brain damage, and its associated cognitive and physical problems, from mid to later life. Recognizing the earliest stages leading to WMH development will provide important opportunities to prevent (or even reverse) brain damage due to small vessel disease at the earliest stages, and ameliorate its cognitive, physical, stroke and dementia consequences.en_UK
Languagedc.language.isoengen_UK
Publisherdc.publisherUniversity of Edinburgh. Centre for Clinical Brain Sciencesen_UK
Relation (Is Referenced By)dc.relation.isreferencedbyhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599520/en_UK
Relation (Is Referenced By)dc.relation.isreferencedbyhttp://jaha.ahajournals.org/content/4/6/e001140en_UK
Rightsdc.rightsCreative Commons Attribution 4.0 International Public Licenseen
Subjectdc.subjectMRIen_UK
Subjectdc.subjectwhite matter hyperintensitiesen_UK
Subjectdc.subjectbrainen_UK
Subjectdc.subjectvascular pathologyen_UK
Subject Classificationdc.subject.classificationSubjects allied to Medicine::Neuroscienceen_UK
Titledc.titleSummary of the computational white matter hyperintensities assessment methods applied to clinical research up to October 2014en_UK
Typedc.typetexten_UK

Download All
zip file MD5 Checksum: 08aa5b1185008371699111d109f421c5

Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record